NASDAQ

Bicycle Therapeutics plc - American Depositary Shares (BCYC)

366 Thanks from members

Bicycle Therapeutics plc (BCYC) displays extreme market volatility with a micro-capitalization valuation around $273 million, trading near $4.00 against an analyst consensus price target averaging roughly $9.50 to $9.86, supported by ongoing oncology pipeline presentations and active institutional ratings.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →